Vexatious criminal proceedings against L’Empaillé, an independent outlet based in southern France, have been dismissed. The outlet had been prosecuted for “public insult” following a complaint by the director of Perpignan’s municipal police, after publishing an investigation into local governance and policing under Mayor Louis Aliot, who is also vice-president of the far-right Rassemblement National party. The case raised concern because it was pursued outside the framework of France’s 1881 press freedom law, which provides safeguards for journalistic expression. In January 2026, the court dismissed the proceedings on procedural grounds. While the court dismissed the case on procedural grounds, the financial and psychological burden of defending such claims is significant for small independent media.
In response to the dismissal, the editorial team at L’Empaillé pledged to “continue to investigate the far right, more than ever.”
Meanwhile, the French Court of Appeal has dismissed a defamation case against Marseille-based news outlet Marsactu. The news site published an investigation into the professional practices of orthopaedic surgeon and knee specialist Michel Assor, who responded with a defamation lawsuit seeking €600,000 in damages.
Marsactu reported that the doctor had numerous legal proceedings and complaints against him from his patients. The news site continued its coverage as the investigation progressed, including after he was formally charged in February 2025 and barred from practising traumatology and orthopaedics. He was accused of intentional violence, unlawful practice of medicine and fraud.
⚖️ L’Empaillé’s and Marsactu’s* legal costs were covered by the Ripostes Fund, created by the Fonds pour une Presse Libre in partnership with Media Defence. The fund ensures independent media can defend themselves against abusive legal action and continue reporting in the public interest.
* Marsactu’s case was initially supported through Media Defence’s Emergency Defence Programme, and later through Ripostes, following the fund’s launch in October 2025.
Read more about the cases below: